Walid Abi-Saab
Chief Tech/Sci/R&D Officer presso UNIQURE N.V.
Patrimonio netto: 606 840 $ in data 31/03/2024
Profilo
Il Dr. Walid Abi-Saab, MD, è un Chief Medical Officer di Galapagos NV. Il dott. Abi-Saab è stato precedentemente impiegato come vicepresidente del gruppo per lo sviluppo clinico presso Shire Plc e come assistente professore di psichiatria e neurochirurgia presso la Yale School of Medicine. Ha ricevuto il suo dottorato dall'Università di Saint Joseph (Macao).
Partecipazioni note in società pubbliche
| Società | Data | Numero di azioni | Valorizzazione | Data di valutazione |
|---|---|---|---|---|
UNIQURE N.V.
0.24% | 01/03/2024 | 116 700 ( 0.24% ) | 606 840 $ | 31/03/2024 |
Posizioni attive di Walid Abi-Saab
| Società | Posizione | Inizio |
|---|---|---|
| UNIQURE N.V. | Chief Tech/Sci/R&D Officer | 26/06/2023 |
Precedenti posizioni note di Walid Abi-Saab
| Società | Posizione | Fine |
|---|---|---|
| GALAPAGOS NV | Chief Tech/Sci/R&D Officer | 31/12/2022 |
Shire International GmbH (Switzerland)
 Shire International GmbH (Switzerland) Pharmaceuticals: MajorHealth Technology Part of Takeda Pharmaceutical Co., Ltd., Shire International GmbH is a pharmaceutical company based in Zug, Switzerland. The Swiss company develops, manufactures, and markets pharmaceuticals. | Corporate Officer/Principal | - |
| SHIRE | Corporate Officer/Principal | - |
| Yale School of Medicine | Corporate Officer/Principal | - |
Formazione di Walid Abi-Saab
| American University of Beirut | Undergraduate Degree |
| Université Saint-Joseph | Doctorate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 2 |
|---|---|
| GALAPAGOS NV | Health Technology |
| UNIQURE N.V. | Health Technology |
| Aziende private | 2 |
|---|---|
Shire Plc
 Shire Plc Pharmaceuticals: MajorHealth Technology Shire Plc is a biopharmaceutical company, which engages in the research, development, licensing, manufacturing, marketing, distribution, and sale of medicines. Its products include adderall, advate, adynovate, agrylin, antithrombin 3, aralast, bebulin, buccolam, feiba, firazyr, and foznol. The company was founded in 1986 and is headquartered in Dublin, Ireland. | Health Technology |
Shire International GmbH (Switzerland)
Shire International GmbH (Switzerland) Pharmaceuticals: MajorHealth Technology Part of Takeda Pharmaceutical Co., Ltd., Shire International GmbH is a pharmaceutical company based in Zug, Switzerland. The Swiss company develops, manufactures, and markets pharmaceuticals. | Health Technology |
- Borsa valori
- Insiders
- Walid Abi-Saab
